What's happening
This bill prohibits step therapy protocols for medically necessary prescription drugs in several therapeutic classes, including non-formulary drugs.
Why it matters
Patients with serious or complex conditions (like cancer, autoimmune diseases, and neurological disorders) would have faster access to the drugs their doctors prescribe. without first having to try and fail insurer-preferred “step” medications that may be less effective for them.
Doctors would gain more authority in treatment decisions for conditions in the specified therapeutic classes. (dermatology, hematology, ophthalmology, rheumatology, gastrointestinal, neurology, oncology), potentially leading to more individualized and timely care.
Non-formulary drugs (those not typically covered by an insurer’s plan) are also protected. , meaning insurance plans can’t use step therapy as a barrier to these drugs when they’re deemed medically necessary—potentially improving outcomes for patients who need less common or newer treatments.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Protect Access to Needed Drugs
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 46
2 Co-sponsors
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Step Therapy for Medicines
In Assembly Committee · Insurance · Sponsor John T. McDonald III
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2682
2023-2024 Regular Sessions
IN SENATE
January 24, 2023
Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law and the public health law, in relation to protecting certain therapeutic classes from step therapy
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (a) of section 4902 of the insurance law is amended by adding a new paragraph 14 to read as follows:
(14) When establishing a step therapy protocol, a utilization review agent shall ensure that such protocol shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.
§ 2. Section 4902 of the public health law is amended by adding a new subdivision 5 to read as follows:
5. When establishing a step therapy protocol, a utilization review agent shall ensure that such protocol shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.
§ 3. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02499-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law and the public health law, in relation to protecting certain therapeutic classes from step therapy
Purpose or general idea of bill
The purpose of this bill is to prevent plans from implementing step therapy policies for certain progressive diseases.
Summary of provisions
Section one amends section 4902 of the insurance law to prohibit a utilization review agent from applying a step therapy protocol to medically necessary prescription drugs in dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.
Section two amends section 4902 of the public health law to reflect the same requirement as section one.
Section three requires that this act shall take effect immediately.
Justification
Step therapy interferes with the prescriber-patient relationship and delays access to necessary care, which can negatively impact patients' health. This is especially true for those with progressive diseases who require timely access to their prescribed treatment to avoid advancing the condition and potentially causing irreversible harm.
Prior legislative history
S8193 - 2021/22
Fiscal implications
None
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.